Lili Zhu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Protein & cell

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Cunjian Shi, Longfeng Chang, Jie Wang, Jingqi Dai, Wenyue Xu, Jiangyang Tang, Wenyi Mei, Chen Zhang, Zedong Wang, Yichen Liao, Xingsen Zhang, Wenzhe Jiang, Guozhen Zhang, Zhenjiang Zhao, Yufang Xu, Lili Zhu, HongLin Li
Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73. Journal of medicinal chemistry 67 (11) (2024)
Cunjian Shi, Longfeng Chang, Jie Wang, Jingqi Dai, Wenyue Xu, Jiangyang Tang, Wenyi Mei, Chen Zhang, Zedong Wang, Yichen Liao, Xingsen Zhang, Wenzhe Jiang, Guozhen Zhang, Zhenjiang Zhao, Yufang Xu, Lili Zhu, HongLin Li
Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73. Journal of medicinal chemistry (2024)
Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, HongLin Li, Ke Xu
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & cell (2020)
Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillette, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, HongLin Li, Ke Xu
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & cell (2020)
Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, HongLin Li, Ke Xu
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & cell 11 (10) (2020)

Lili Zhu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lili Zhu